Stat-Gent joined the SISAQOL consortium

(25-09-2020)

SISAQOL (Setting International Standards in Analyzing Patient-Reported Outcomes and Quality oLife endpoints) is an international Consortium of experts convened with the aim to develop recommendations for the analysis of patient reported outcomes (PRO) data in cancer randomized trials. The SISAQOL consortium consists of leading HRQoL researchers and statisticians, key individuals from various international medical societies, advisory and regulatory bodies, academic societies, pharmaceutical industry, cancer institutes and patient advocacy organizations. Recently, Stat-Gent joined the statistical methods working group of the SISAQOL consortium to develop guidelines for the design and analysis of PRO measures for non-RCTs in cancer studies with a specific focus on single-arm studies.